SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 149 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q1 2018. The put-call ratio across all filers is 1.65 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $0 | -100.0% | 2,000 | -50.0% | 0.00% | -100.0% |
Q3 2018 | $7,000 | 0.0% | 4,000 | 0.0% | 0.00% | -33.3% |
Q2 2018 | $7,000 | 0.0% | 4,000 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $7,000 | -22.2% | 4,000 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $9,000 | -25.0% | 4,000 | 0.0% | 0.00% | -25.0% |
Q3 2017 | $12,000 | -33.3% | 4,000 | 0.0% | 0.00% | -33.3% |
Q2 2017 | $18,000 | -5.3% | 4,000 | 0.0% | 0.01% | -14.3% |
Q1 2017 | $19,000 | -20.8% | 4,000 | 0.0% | 0.01% | -36.4% |
Q4 2016 | $24,000 | +9.1% | 4,000 | 0.0% | 0.01% | 0.0% |
Q3 2016 | $22,000 | +46.7% | 4,000 | 0.0% | 0.01% | +37.5% |
Q2 2016 | $15,000 | +150.0% | 4,000 | +100.0% | 0.01% | +166.7% |
Q1 2016 | $6,000 | -45.5% | 2,000 | 0.0% | 0.00% | -50.0% |
Q4 2015 | $11,000 | 0.0% | 2,000 | 0.0% | 0.01% | -14.3% |
Q3 2015 | $11,000 | -35.3% | 2,000 | 0.0% | 0.01% | -30.0% |
Q2 2015 | $17,000 | +88.9% | 2,000 | 0.0% | 0.01% | +100.0% |
Q1 2015 | $9,000 | – | 2,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Asymmetry Capital Management, L.P. | 477,621 | $1,065,000 | 1.44% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 1,505,804 | $3,358,000 | 1.18% |
Nantahala Capital Management | 7,000,000 | $15,610,000 | 0.69% |
Hikari Power Ltd | 1,900,000 | $4,237,000 | 0.50% |
Trellus Management Company, LLC | 112,500 | $251,000 | 0.34% |
Cheyne Capital Management (UK) LLP | 206,500 | $462,000 | 0.20% |
KNOTT DAVID M | 201,400 | $449,000 | 0.18% |
Paulson & Co. | 4,000,000 | $8,920,000 | 0.17% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,041,695 | $2,323,000 | 0.15% |
Clear Harbor Asset Management, LLC | 318,460 | $710,000 | 0.13% |